Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Marinò M, Latrofa F, Menconi F, Chiovato L, Vitti P. Role of genetic and non-genetic factors in the etiology of Graves' disease. J Endocrinol Invest. 2015 Mar;38(3):283-94. doi:10.1007/s40618-014-0214-2.
Nakano A, Watanabe M, Iida T, et al. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid. 2007 Jan;17(1):25-31. doi: 10.1089/thy.2006.0231.
Ben-Skowronek I, Szewczyk L, Kulik-Rechberger B, Korobowicz E. The differences in T and B cell subsets in thyroid of children with Graves' disease and Hashimoto's thyroiditis. World J Pediatr. 2013 Aug;9(3):245-50. doi:10.1007/s12519-013-0398-0.
Tomczyńska M, Saluk-Bijak J. The mutual cooperation of blood platelets and lymphocytes in the development of autoimmune thyroid diseases. Acta Biochim Pol. 2018;65(1):17-24. doi:10.18388/abp.2017_2321.
Mikoś H, Mikoś M, Obara-Moszyńska M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 2014;65(2):150-5. doi:10.5603/EP.2014.0021.
Ząbczyńska M, Polak K, Kozłowska K, Sokołowski G, Pocheć E. The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto's Thyroiditis: An in Vitro Model of Thyroid Autoimmunity. Biomolecules. 2020 Jan 22;10(2):171. doi:10.3390/biom10020171.
Russo-Carbolante EM, Polizzelo AC, Azzolini AE, Maciel LM, Lucisano-Valim YM. Neutrophils from Brazilian patients with Graves' disease: some biochemical and functional aspects. Cell Biochem Funct. 2005 Sep-Oct;23(5):297-306. doi: 10.1002/cbf.1164.
Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res. 2011 Oct;31(10):721-31. doi:10.1089/jir.2011.0049.
Qin Q, Liu P, Liu L, et al. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease. Braz J Med Biol Res. 2012 Dec;45(12):1202-8. doi: 10.1590/s0100-879x2012007500168.
Ben-Skowronek I, Szewczyk L, Ciechanek R, Korobowicz E. Interactions of lymphocytes, thyrocytes and fibroblasts in Hashimoto's thyroiditis: an immunohistochemical and ultrastructural study. Horm Res Paediatr. 2011;76(5):335-42. doi:10.1159/000331857.
Bossowski A, Harasymczuk J, Moniuszko A, Bossowska A, Hilczer M, Ratomski K. Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases. Thyroid Res. 2011 Sep 23;4:13. doi:10.1186/1756-6614-4-13.
Akesson C, Uvebrant K, Oderup C, et al. Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency. Clin Exp Immunol. 2010 Jul 1;161(1):48-56. doi:10.1111/j.1365-2249.2010.04114.x.
Wang Y, Yuan W, Guo H, Jiang Y. High frequency of activated NKp46(+) natural killer cells in patients with new diagnosed of latent autoimmune diabetes in adults. Autoimmunity. 2015 Jun;48(4):267-73. doi: 10.3109/08916934.2014.990629.
Kyritsi EM, Yiakoumis X, Pangalis GA, et al. High Frequency of Thyroid Disorders in Patients Presenting With Neutropenia to an Outpatient Hematology Clinic STROBE-Compliant Article. Medicine (Baltimore). 2015 Jun;94(23):e886. doi:10.1097/MD.0000000000000886.
Guo H, Xu B, Yang X, et al. A high frequency of peripheral blood NKG2D+NK and NKT cells in euthyroid patients with new onset hashimoto's thyroiditis--a pilot study. Immunol Invest. 2014;43(4):312-23. doi:10.3109/08820139.2013.854377.
Zhang Y, Lv G, Lou X, et al. NKG2A expression and impaired function of NK cells in patients with new onset of Graves' disease. Int Immunopharmacol. 2015 Jan;24(1):133-9. doi:10.1016/j.intimp.2014.09.020.
Zakharchenko TF, Gulevaty SV, Volynets IP. Comparative analysis of the activity of cells of innate immunity in patients with benign and malignant thyroid diseases after radioiodine therapy. Mìžnarodnij endokrinologìčnij žurnal. 2019;15(3):210-216. doi:10.22141/2224-07126.96.36.1999.172106. (in Ukrainian).
Harlin H, Hanson M, Johansson CC, et al. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J Immunol. 2007 Oct 1;179(7):4513-9. doi:10.4049/jimmunol.179.7.4513.
Bossowski A, Moniuszko M, Idźkowska E, et al. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases. Autoimmunity. 2016 Aug;49(5):320-8. doi: 10.1080/08916934.2016.1183654.
Kristensen B, Hegedüs L, Madsen HO, Smith TJ, Nielsen CH. Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis. Clin Exp Immunol. 2015 Apr;180(1):58-69. doi:10.1111/cei.12557.
Liu Y, Cui X, Wang S, et al. Elevated MicroRNA-326 Levels Regulate the IL-23/IL-23R/Th17 Cell Axis in Hashimoto's Thyroiditis by Targeting a Disintegrin and Metalloprotease 17. Thyroid. 2020 Sep;30(9):1327-1337. doi:10.1089/thy.2019.0552.
Van der Weerd K, Van Hagen PM, Schrijver B, et al. The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes. Clin Exp Immunol. 2013 Nov;174(2):256-64. doi:10.1111/cei.12183.
Bossowski A, Grubczak K, Singh P, et al. Analysis of B regulatory cells with phenotype CD19+CD24hiCD27+IL-10+ and CD19+IL-10+ in the peripheral blood of children with Graves’ disease and Hashimoto’s thyroiditis. Pediatr Endocrinol. 2015;14(Suppl 1):40.
Kemp EH, Ajjan RA, Metcalfe RA, Watson PF, Weetman AP. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis. Clin Endocrinol (Oxf). 2015 Nov;83(5):726-32. doi:10.1111/cen.12810.
Sun L, Zhang X, Dai F, Shen J, Ren C, Zuo C, Zhang Q. Elevated interleukin-1β in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis. Endocr Res. 2016 Aug;41(3):185-92. doi: 10.3109/07435800.2015.1124439.
Sheremet MI. Apoptosis of blood lymphocytes in patients with autoimmune thyroiditis and its treatment. Mìžnarodnij endokrinologìčnij žurnal. 2018;14(3):252-257. doi:10.22141/2224-07188.8.131.528.136421. (in Ukrainian).
Yan YR, Gao XL, Zeng J, et al. The association between thyroid autoantibodies in serum and abnormal function and structure of the thyroid. J Int Med Res. 2015 Jun;43(3):412-23. doi:10.1177/0300060514562487.
Hu YM, Liu W, Lu GH. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism]. Zhonghua Yi Xue Za Zhi. 2003 Jun 10;83(11):940-2. (in Chinese).